{"schema_version":"1","generated_at":"2026-11-01T11:29:33.333Z","data_as_of":null,"url":"https://www.findmykol.com/kol/mintallah-haider","json_url":"https://www.findmykol.com/kol/mintallah-haider/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"mintallah-haider","name":"Mintallah Haider","credential":"MD","specialty":"Medical Oncology","specialty_raw":"Medical Oncology","therapeutic_area":"Oncology","therapeutic_areas":["Oncology"],"institution":"Moffitt Cancer Center","institution_url":"https://www.findmykol.com/institution/moffitt-cancer-center","city":"Tampa","state":"FL","region":{"label":"Southeast","url":"https://www.findmykol.com/region/southeast"}},"identifiers":{"npi":"1235400284","openalex":"A5079239247"},"summary":"Mintallah Haider is an Oncology physician affiliated with Moffitt Cancer Center. OpenAlex indexes 63 publications with 382 citations (h-index 11).","overview":null,"focus":{"indications":[],"research_topics":["Oncology"]},"scholarship":{"works_count":63,"cited_by_count":382,"h_index":11,"latest_activity_year":2026,"source":"works"},"payments":{"company_count":7,"program_years":{"first":2021,"last":null},"rows_total":14,"shown":3,"withheld":11,"rows":[{"payer":"Exelixis Inc.","program_year":2025,"amount_usd":8762.03,"payment_count":16,"source_url":"https://openpaymentsdata.cms.gov/search?query=1235400284"},{"payer":"Novartis Pharmaceuticals Corporation","program_year":2025,"amount_usd":1400,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1235400284"},{"payer":"Boehringer Ingelheim Pharmaceuticals, Inc.","program_year":2025,"amount_usd":58.65,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1235400284"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1235400284","source":"payments"},"prescribing":{"data_year":2024,"areas_total":5,"areas_shown":3,"areas":[{"area":"Metabolism & gastrointestinal","share_pct":52.2,"classes_total":3,"classes":[{"class":"Serotonin-3 Receptor Antagonist","setting":"prescribed","share_pct":39,"drugs":[{"name":"Ondansetron Hcl","share_pct":100}],"max_beneficiaries":33},{"class":"Antidiarrheal microorganisms","setting":"prescribed","share_pct":7.2,"drugs":[{"name":"Creon","share_pct":100}],"max_beneficiaries":null}]},{"area":"Nervous system","share_pct":25.3,"classes_total":3,"classes":[{"class":"Phenothiazine","setting":"prescribed","share_pct":10.4,"drugs":[{"name":"Prochlorperazine Maleate","share_pct":100}],"max_beneficiaries":18},{"class":"Opioid Agonist","setting":"prescribed","share_pct":10,"drugs":[{"name":"Oxycodone Hcl","share_pct":100}],"max_beneficiaries":15}]},{"area":"Blood & clotting","share_pct":10,"classes_total":1,"classes":[{"class":"Factor Xa inhibitor","setting":"prescribed","share_pct":10,"drugs":[{"name":"Eliquis","share_pct":100}],"max_beneficiaries":null}]}],"care_setting":{"dominant":"mixed","data_year":2024,"office_pct":49.2,"facility_pct":50.8},"source":"medicare"},"publications":{"total":50,"shown":5,"withheld":45,"matched_by":"OpenAlex author record","recent":[{"title":"Somatostatin Receptor Expression on [ <sup>68</sup> Ga]Ga-DOTATATE PET Among Patients with Poorly Differentiated Extrapulmonary Neuroendocrine Carcinomas: A Prospective Study","year":2026,"journal":"Journal of Nuclear Medicine","source_url":"https://doi.org/10.2967/jnumed.125.271460","status":"verified"},{"title":"Leveraging early-onset adverse events (AEs) to inform treatment strategies in pan-gastrointestinal (GI) cancer.","year":2026,"journal":"Journal of Clinical Oncology","source_url":"https://doi.org/10.1200/jco.2026.44.2_suppl.842","status":"verified"},{"title":"Somatostatin Receptor Expression of Gastroenteropancreatic Neuroendocrine Tumors: A Comprehensive Analysis in the Era of Somatostatin Receptor PET Imaging","year":2025,"journal":"Cancers","source_url":"https://doi.org/10.3390/cancers17121937","status":"verified"},{"title":"Association Between Long-Term Proton Pump Inhibitor Use and Low-Risk Gastric Neuroendocrine Tumors","year":2025,"journal":"Annals of Surgical Oncology","source_url":"https://doi.org/10.1245/s10434-025-18430-2","status":"verified"},{"title":"A phase II study of neratinib (Nera) in combination with chemotherapy/trastuzumab/pembrolizumab (C/T/P) in HER2 overexpressing gastroesophageal cancers (GECs).","year":2025,"journal":"Journal of Clinical Oncology","source_url":"https://doi.org/10.1200/jco.2025.43.4_suppl.tps514","status":"verified"}],"source":"works"},"contact":{"address_1":"12902 USF MAGNOLIA DR","city":"Tampa","state":"FL","zip":"336129416","phone":"813-745-4673","source_url":"https://npiregistry.cms.hhs.gov/provider-view/1235400284","source":"identity"},"similar":[{"name":"Ignacio Wistuba","slug":"ignacio-wistuba","institution":"Moffitt Cancer Center","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/ignacio-wistuba","json_url":"https://www.findmykol.com/kol/ignacio-wistuba/profile.json"},{"name":"Christine Chung","slug":"christine-chung","institution":"Moffitt Cancer Center","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/christine-chung","json_url":"https://www.findmykol.com/kol/christine-chung/profile.json"},{"name":"Jonathan Strosberg","slug":"jonathan-strosberg","institution":"Moffitt Cancer Center","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/jonathan-strosberg","json_url":"https://www.findmykol.com/kol/jonathan-strosberg/profile.json"},{"name":"Nikhil Khushalani","slug":"nikhil-khushalani","institution":"Moffitt Cancer Center","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/nikhil-khushalani","json_url":"https://www.findmykol.com/kol/nikhil-khushalani/profile.json"},{"name":"Carl June","slug":"carl-june","institution":"University of Pennsylvania","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/carl-june","json_url":"https://www.findmykol.com/kol/carl-june/profile.json"},{"name":"Rainer Storb","slug":"rainer-storb","institution":"University of Washington","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/rainer-storb","json_url":"https://www.findmykol.com/kol/rainer-storb/profile.json"},{"name":"Christina Fitzmaurice","slug":"christina-fitzmaurice","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/christina-fitzmaurice","json_url":"https://www.findmykol.com/kol/christina-fitzmaurice/profile.json"},{"name":"Larry Norton","slug":"larry-norton","institution":"Memorial Sloan Kettering Cancer Center","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/larry-norton","json_url":"https://www.findmykol.com/kol/larry-norton/profile.json"}],"coverage":{"note":"A basic record from the physician directory. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["funding","congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"payments":11,"publications":45}},"sources":{"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician","coverage":"Practice location (not mailing) from the NPPES record","record_last_updated":"2025-07-14","provider_certified":"2025-07-14","collected_at":"2026-10-31T00:00:00.000Z"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"},"medicare":{"name":"CMS Medicare Part D Prescribers and Part B","url":"https://data.cms.gov/provider-summary-by-type-of-service","provides":"Share of this prescriber's Medicare fee-for-service prescribing by drug class and therapeutic area, classified with WHO ATC and NLM RxClass","disclaimer":"Proportions of the prescriber's own classified prescribing, never patient counts or dollar amounts. Fee-for-service only; CMS publishes about 17 months after the fact and suppresses counts of ten patients or fewer.","data_year":2024}},"methodology_url":"https://www.findmykol.com/about#methodology"}